Search research articles
Contact Us
Filters
Showing results (361-370 of 367) with videos related to
Page
of 37
Sort By:
You have reached the last page of results.
This site can display upto 367 results.
The Pharmacogenomics Journal
|
August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy
S Matsusaka, S Cao, D L Hanna, et al.
Mayo Clinic Proceedings
|
February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
Dalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
S Stintzing, P Wirapati, H-J Lenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2021
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy
J Y Wang, J Xiu, Y Baca, et al.
Nature
|
March 10, 2001
A high-resolution map of human chromosome 12
K T Montgomery, E Lee, A Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
T Yoshino, J M Cleary, E Van Cutsem, et al.
Page
of 37
Search research articles
Search
Showing results (361-370 of 367) with videos related to
Sort By:
Page
of 37
You have reached the last page of results.
This site can display upto 367 results.
The Pharmacogenomics Journal
|
August 10, 2016
CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy
S Matsusaka, S Cao, D L Hanna, et al.
Mayo Clinic Proceedings
|
February 10, 2019
Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism
Dalene M Bott-Kitslaar, Robert D McBane, Ana I Casanegra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2019
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial
S Stintzing, P Wirapati, H-J Lenz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2021
Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy
J Y Wang, J Xiu, Y Baca, et al.
Nature
|
March 10, 2001
A high-resolution map of human chromosome 12
K T Montgomery, E Lee, A Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
T Yoshino, J M Cleary, E Van Cutsem, et al.
Page
of 37